Medications like semaglutide and tirzepatidecollectively known as GLP-1 receptor agonistshave transformed how we approach type 2 diabetes and obesity
Potential Cardiovascular Benefits : Some GLP-1 agonists, such as semaglutide, have shown to reduce the risk of major cardiovascular events (e.g., heart attacks, strokes), particularly in patients with type 2 diabetes
Research shows that GLP-1 discontinuation rates are highup to 50%with many patients stopping within the first year due to cost, side effects or lack of comprehensive support, says Hall of apree health
Typically self-limiting
Personalized Care : We tailor each prescription to your specific needs, maintaining the highest standards of quality and safety
If this ends up being you, dont lose hope